What triggered MetLife shares' latest price pullback

Traders Union
All News
Financial News
Metlife slides 3.62% today on pressure

Highlights

MetLife reported Q1 2026 adjusted EPS of $2.42, exceeding expectations despite a modest revenue shortfall.
The annual meeting saw all directors re-elected, executive pay confirmed, and regular dividends and capital returns maintained.
Downside pressure persists near $84.84, but technical signals suggest an 80%+ probability of sideways to bullish price action between $82.51 and $86.31 this week.

Bullish earnings and governance stability counter broader selling bias

MetLife Inc reported adjusted earnings per share of $2.42 for the first quarter of 2026, surpassing consensus estimates, with a minor revenue miss. The company held its annual shareholder meeting on June 16, 2026, where eleven directors were elected to serve through 2027, an independent auditor was ratified, and executive compensation policies were approved. MetLife also confirmed the continuation of its regular common dividend and ongoing capital-return program, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, notes MetLife’s accelerated sell-off despite delivering strong first-quarter earnings and stable governance. He sees the break below the 20-day moving average and the session’s volatility as warning signs. Technical momentum remains mixed, with lingering downside risks and overbought signals. Short-term pressures could invalidate the otherwise bullish structure. "Until price reclaims $84.96 with conviction, I expect persistent weakness and recommend caution on new long entries."

Viktoras Karapetjanc, expert at Traders Union, emphasizes MetLife’s resilience after surpassing earnings expectations and reaffirming its capital-return commitments. He sees continued governance stability as reinforcing investor confidence. The current setup suggests the bullish trend framework remains intact, with momentum and fundamentals pointing to further growth. "Investors should focus on upside scenarios, as the market offers multiple setups for renewed strength above $86.31."

Short-term weakness amid positive momentum and trend support

MetLife is trading below its 20-day moving average at $84.96, but stays above the 50-day ($81.35) and 200-day ($78.25) moving averages, highlighting a short-term dip within an otherwise bullish trend framework. Price action is anchored by Ichimoku Kijun support at $83.97. The near-term floor is set at today’s low of $84.48, with immediate resistance at $84.96. Momentum indicators are mostly positive: MACD and ADX signal underlying buying interest, the CCI remains strong, and the RSI remains buy-leaning. Intraday metrics show Bull/Bear Power favoring buyers, though hinting at overbought conditions, and the Stochastic RSI is neutral. The stock is near its session low after an intraday drop to $84.84 with 4.21% volatility, reflecting significant downside pressure and mixed short-term momentum signals.

Earlier, analysts noted that MetLife demonstrated underlying technical and operational strength, with momentum favoring a bullish continuation. The recent price pullback highlights an important inflection point, making a sustained move above $86.31 the key signal for renewed upside in the days ahead.

Source of Data: MET Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.